v3.26.1
Business Combinations and Contingent Consideration Liabilities - Schedule of Contingent Consideration, Measured at Fair Value (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Business Combination [Line Items]    
Balance $ 37,711  
Change in estimated fair value 5,946 $ (4,275)
Balance 43,455 37,711
Fair Value, Inputs, Level 3 [Member] | Insight Genetics Inc [Member]    
Business Combination [Line Items]    
Balance 2,593 2,040
Change in estimated fair value (786) 553
Balance 1,807 2,593
Fair Value, Inputs, Level 3 [Member] | Chronix Merger [Member]    
Business Combination [Line Items]    
Balance 35,346 40,174
Earnout payments (2)  
Change in estimated fair value 6,732 (4,828)
Balance $ 42,076 $ 35,346